Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder

Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder

Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e16-e16
Hauptverfasser: Papaseit, E, Garcia-Algar, O, Aznar, G, Marchei, E, Pacifici, R, Pichini, S, Farré, M
Format: Artikel
Sprache:eng
Schlagworte:
Attention deficit hyperactivity disorder
Fluids
Internal Medicine
Medical Education
Plasma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.056